COMMUNIQUÉS West-GlobeNewswire

Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment
17/09/2025
Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA Approval KANSAS CITY, Kan., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company [...]
Akari Therapeutics Announces Filing for New Patent for Novel ADC Platform Utilizing Spliceosome Payload PH1 for the Treatment of Cancer
17/09/2025
BOSTON and LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that it has filed [...]
Propanc Biopharma Receives Certificate of Grant for “Proenzyme Composition” Patent from US Patent & Trademark Office
17/09/2025
Fourth US Granted Patent Captures Claims for Future Clinical Dose of PRP MELBOURNE, Australia, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical [...]
NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy
17/09/2025
LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The world’s first therapeutic drug to be equipped with NovalGen’s pioneering AutoRegulation (AR) technology has been approved for evaluation in the clinic by the UK’s Medicine [...]
ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair
17/09/2025
– Accomplished biopharma executive and entrepreneur brings a 25-year track record of upscaling valuable companies and realizing the potential of their innovations – SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- ADARx [...]
Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data
17/09/2025
PALI-2108 demonstrated favorable safety, with no serious adverse events, lab abnormalities, or EKG concerns Phase 1b data demonstrated 100% clinical response and promising signals regarding the efficacy of PALI-2108 in [...]
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
17/09/2025
HilleVax Stockholders Received $1.95 Per Share in Cash Plus a Contingent Value Right EMERYVILLE, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a [...]
Nylon flexTAP®: First FDA cleared 3D-Printed Midline Oral Appliance for Sleep Apnea
17/09/2025
DALLAS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Airway Management proudly announces a historic milestone with the FDA clearance of Nylon flexTAP ® , the world’s first digitally printed single-point midline oral appliance [...]
Synergy CHC Corp. (NASDAQ: SNYR) Partners with AlaBev to Launch FOCUSfactor® Beverages in 5,000+ Retail Outlets Across Alabama
17/09/2025
WESTBROOK, Maine, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) , a leading consumer health and wellness company, today announced a strategic distribution partnership with AlaBev , one of the [...]
24/7 Market News: Kraig Labs Spider Silk is Sustainable Alternative to Petroleum-Derived Plastics
17/09/2025
Nylon and Polyester Are Polluting the Planet with Microplastics DENVER, Sept. 17, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and [...]
New Study Highlights the Potential of Hyperbaric Oxygen Therapy as a Biologically Based Treatment for Long-Term PTSD Symptom Improvement
17/09/2025
The study examined the long-term relief of PTSD symptoms in male veterans, highlighting the significant impact HBOT can have on alleviating the debilitating daily challenges they face ORLANDO, Fla., Sept. 17, 2025 ( [...]
Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agonist-induced Weight Loss by Preserving Lean Mass, Presented at EASD
17/09/2025
Complete 26-week results further demonstrate that combining semaglutide with trevogrumab (anti-GDF8/anti-myostatin) helped prevent about half of semaglutide-induced loss of lean mass, while increasing fat mass loss [...]
Acentra Health Named one of the ‘Fastest Growing Companies’ by the Washington Business Journal
17/09/2025
Recognition highlights Acentra Health’s role as a vital healthcare partner to its growing roster of clients MCLEAN, Va., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health solutions and services [...]
Notice of Annual General Meeting 2025
17/09/2025
ANNOUNCEMENT NO. 293 17 September 2025 Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 9 October 2025 at 5.30 p.m. The general meeting will be held [...]
Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection
17/09/2025
NESS ZIONA, Israel, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on developing innovative long-acting depot injectable [...]
Foundation for Sarcoidosis Research Reacts to the Announcement of aTyr Pharma’s Phase 3 Clinical Trial Results
17/09/2025
CHICAGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) expresses both solidarity and resolve as aTyr Pharma announced that its Phase 3 trial of efzofitimod in pulmonary sarcoidosis did [...]
MyCardiologist Launches Immediate Care Clinic, Offering Same-Day Access to Expert Cardiac Care
17/09/2025
MyCardiologistNow provides a new walk-in clinic for patients needing prompt evaluation of non-life-threatening heart symptoms MIAMI, Sept. 17, 2025 (GLOBE NEWSWIRE) -- MyCardiologist , one of South Florida’s leading [...]
Celldex Presents Data Demonstrating Barzolvolimab Improves Chronic Spontaneous Urticaria Independent of Baseline Immunoglobulin E levels in Phase 2 Study at EADV Congress 2025
17/09/2025
Rapid and sustained efficacy regardless of baseline IgE levels in patients with CSU HAMPTON, N.J., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today new data demonstrating rapid and strong [...]
Amphista Therapeutics discloses first details of its SMARCA2 degrader program
17/09/2025
Structurally-guided discovery using high-resolution cryo-EM has delivered potent, DCAF16-dependent Targeted Glues™ of SMARCA2, with exquisite selectivity over close homolog, SMARCA4. Rapid, deep and sustained [...]

Pages